|
2型糖尿病血脂异常临床研究进展 |
| |
SM, Americ
an Diabetes Association. Dyslipidemia management in adults with diabetes. Diabetes Care,2004,27（Suppl 1）:S68-S71.
10 De Backer G, Ambrosioni E, Borch-Johnsen K, et al. Executive Summary. European guideline on cardiovascular disease prevention in clinical practice. Third joint task force of European and other societies on cardiovascular disease prevention in clinical practice. Eur Heart J,2003,24:1601-1610.
11 Grundy SM, Cleeman JI, Merz NB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel 3 guidelines. Circulation,2004,110:227-239.
12 ADA. Diabetes care. Jam,2001,24（suppl 1）:S58-S61.
13 Pyorala K, Pederson TR, Kjekshus J, et al. For the Scandinavian Simvastalin Survival Study: cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the scandinavian Survival Study（4S）. Diabetes Care,1997,20:614-620.
14 Colhon HM, Betteridge DJ, Durrington PN, et al. Primary prevention of cardiovascular disease with atorvastain in type 2 diabetes in the Collaborstive AtoRvastatin Diabetes Study（CARDS）: a multicentre randomized placebo-controlled trail. Lancet,2004,110:227-239.
15 Pan J, Vand JT, Chan E, et al. Extended-release niacin treatment of the atherogenic lipid profile and lipoprotein in diabetes. Metabolism,2002,51:1120-1127.
16 Ridker PM, Canon CP, Morrow, et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med,2005,352:20-28.
17 陈新谦.新编药物学，第15版.北京：人民卫生出版社，2002，383-385.
18 Steiner G, Stewart D, Hosking JD. Baseline characteristics of the study population in the diabetes Atheroscerosis Intervention Study（DAIS）. World Health Organization Collabrating Centre for the Study of Atherosclerosis in Diabetes. Am J Cardiol,1999,84（9）:1004-1010.
19 Bloomfield RH, Savenport J, Babikian V, et al. Redu上一页 [1] [2] [3] [4] [5] 下一页
上一个医学论文： 微生态制剂预防小儿肺炎继发腹泻的临床观察
下一个医学论文： 妊娠期肝内胆汁淤积症42例临床分析
|
|
|
您现在的位置： 绿色健康网 >> 医学论文 >> 儿科论文 >> 正文